Clinical Trials Browser

Phase 2 × Itraconazole × Other hematologic neoplasm × Clear all

NCT05048615 2023-01-25

Low-dose Venetoclax and Azacitidine as Front-line Therapy in Newly Diagnosed AML

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute